ID

21758

Beschrijving

A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL); ODM derived from: https://clinicaltrials.gov/show/NCT00363636

Link

https://clinicaltrials.gov/show/NCT00363636

Trefwoorden

Versies (1)
  1. 28-04-17 28-04-17 -
Geüploaded op

28 april 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Lymphoma, Non-Hodgkin's NCT00363636

Engels

Eligibility Lymphoma, Non-Hodgkin's NCT00363636

1 Formulieren  
Criteria
Beschrijving

Criteria

key inclusion criteria:
Beschrijving

Inclusion criteria Main

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1542147
aged >= 18 years old at the time of informed consent.
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
histologically confirmed follicular grade 1-3a nhl.
Beschrijving

Follicular Lymphoma Ann Arbor lymphoma staging system

Datatype

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0432516
relapsed or progressive disease after at least 1 prior chemotherapy requiring treatment.
Beschrijving

Chemotherapy Quantity Requirement Therapeutic procedure | Recurrent disease | Progressive Disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C1514873
UMLS CUI [1,4]
C0087111
UMLS CUI [2]
C0277556
UMLS CUI [3]
C1335499
bidimensionally measurable disease with at least 1 lesion >= 2.0 cm in a single dimension.
Beschrijving

Measurable Disease 2-Dimensional | Lesion Diameter Quantity

Datatype

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C1301886
UMLS CUI [2,3]
C1265611
acceptable hematologic, hepatic, and renal function parameters.
Beschrijving

Hematologic function | Liver function | Renal function

Datatype

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
recovered fully from any significant toxicity associated with prior surgery, radiation treatments, chemotherapy, biological therapy, autologous bone marrow or stem cell transplant, or investigational drugs.
Beschrijving

Toxicity Patient recovered | Operative Surgical Procedures | Therapeutic radiology procedure | Chemotherapy | Biological treatment | Autologous bone marrow transplant | Transplantation of autologous hematopoietic stem cell | Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C1115804
UMLS CUI [2]
C0543467
UMLS CUI [3]
C1522449
UMLS CUI [4]
C0392920
UMLS CUI [5]
C1531518
UMLS CUI [6]
C0194037
UMLS CUI [7]
C1831743
UMLS CUI [8]
C0013230
key exclusion criteria:
Beschrijving

Exclusion Criteria Main

Datatype

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
follicular lymphoma grade 3b.
Beschrijving

Follicular Lymphoma Ann Arbor lymphoma staging system

Datatype

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0432516
rituximab refractory or refractory to anti-cd20 radioimmunotherapy (no response to prior rituximab or prior rituximab-containing regimen, or a response with a ttp of less than 6 months).
Beschrijving

rituximab refractory | Radioimmunotherapy Against CD20 Antigens refractory | Thrombotic Thrombocytopenic Purpura Duration Disease Response

Datatype

boolean

Alias
UMLS CUI [1,1]
C0393022
UMLS CUI [1,2]
C0205269
UMLS CUI [2,1]
C0085101
UMLS CUI [2,2]
C0521124
UMLS CUI [2,3]
C0054946
UMLS CUI [2,4]
C0205269
UMLS CUI [3,1]
C0034155
UMLS CUI [3,2]
C0449238
UMLS CUI [3,3]
C1704632
cancer radiotherapy, biological therapy, or chemotherapy within 3 weeks prior to study day 1 (6 weeks if nitrosourea or mitomycin c).
Beschrijving

Therapeutic radiology procedure Malignant Neoplasms | Biological treatment Malignant Neoplasms | Chemotherapy Malignant Neoplasms | Nitrosourea | Mitomycin-c

Datatype

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0006826
UMLS CUI [2,1]
C1531518
UMLS CUI [2,2]
C0006826
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C0006826
UMLS CUI [4]
C0028210
UMLS CUI [5]
C0002475
prior lymphoma vaccine therapy within 12 months prior to study day 1.
Beschrijving

Vaccine Therapy Lymphoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0042209
UMLS CUI [1,2]
C0024299
prior antibody therapy for lymphoma (including radioimmunotherapy) within 6 months prior to study day 1.
Beschrijving

Antibody therapy Lymphoma | Radioimmunotherapy Lymphoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0281176
UMLS CUI [1,2]
C0024299
UMLS CUI [2,1]
C0085101
UMLS CUI [2,2]
C0024299
autologous bone marrow or stem cell transplant within 6 months prior to study day 1.
Beschrijving

Autologous bone marrow transplant | Transplantation of autologous hematopoietic stem cell

Datatype

boolean

Alias
UMLS CUI [1]
C0194037
UMLS CUI [2]
C1831743
prior allogeneic transplant.
Beschrijving

Transplantation, Homologous

Datatype

boolean

Alias
UMLS CUI [1]
C0040739
transfusion-dependent subjects.
Beschrijving

Blood transfusion dependent

Datatype

boolean

Alias
UMLS CUI [1]
C1698624
another primary malignancy requiring active treatment (except hormonal therapy).
Beschrijving

Primary tumor Requirement Therapeutic procedure | Hormone Therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0087111
UMLS CUI [2]
C0279025
serious nonmalignant disease (e.g., congestive heart failure, hydronephrosis); active uncontrolled bacterial, viral, or fungal infections; or other conditions, which would compromise protocol objectives in the opinion of the investigator and/or the sponsor.
Beschrijving

Disease Serious | Congestive heart failure | Hydronephrosis | Bacterial Infections Uncontrolled | Virus Diseases Uncontrolled | Mycoses Uncontrolled | Condition compromises Protocol Compliance

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0018802
UMLS CUI [3]
C0020295
UMLS CUI [4,1]
C0004623
UMLS CUI [4,2]
C0205318
UMLS CUI [5,1]
C0042769
UMLS CUI [5,2]
C0205318
UMLS CUI [6,1]
C0026946
UMLS CUI [6,2]
C0205318
UMLS CUI [7,1]
C0348080
UMLS CUI [7,2]
C2945640
UMLS CUI [7,3]
C0525058
new york heart association class iii or iv cardiac disease or myocardial infarction within 6 months prior to study day 1.
Beschrijving

Heart Disease New York Heart Association Classification | Myocardial Infarction

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C1275491
UMLS CUI [2]
C0027051
Terug naar het begin van de pagina

Similar models

Eligibility Lymphoma, Non-Hodgkin's NCT00363636

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion criteria Main
Item
key inclusion criteria:
boolean
C1512693 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Age
Item
aged >= 18 years old at the time of informed consent.
boolean
C0001779 (UMLS CUI [1])
Follicular Lymphoma Ann Arbor lymphoma staging system
Item
histologically confirmed follicular grade 1-3a nhl.
boolean
C0024301 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
Chemotherapy Quantity Requirement Therapeutic procedure | Recurrent disease | Progressive Disease
Item
relapsed or progressive disease after at least 1 prior chemotherapy requiring treatment.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0277556 (UMLS CUI [2])
C1335499 (UMLS CUI [3])
Measurable Disease 2-Dimensional | Lesion Diameter Quantity
Item
bidimensionally measurable disease with at least 1 lesion >= 2.0 cm in a single dimension.
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
C0221198 (UMLS CUI [2,1])
C1301886 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Hematologic function | Liver function | Renal function
Item
acceptable hematologic, hepatic, and renal function parameters.
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Toxicity Patient recovered | Operative Surgical Procedures | Therapeutic radiology procedure | Chemotherapy | Biological treatment | Autologous bone marrow transplant | Transplantation of autologous hematopoietic stem cell | Investigational New Drugs
Item
recovered fully from any significant toxicity associated with prior surgery, radiation treatments, chemotherapy, biological therapy, autologous bone marrow or stem cell transplant, or investigational drugs.
boolean
C0600688 (UMLS CUI [1,1])
C1115804 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C1531518 (UMLS CUI [5])
C0194037 (UMLS CUI [6])
C1831743 (UMLS CUI [7])
C0013230 (UMLS CUI [8])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Follicular Lymphoma Ann Arbor lymphoma staging system
Item
follicular lymphoma grade 3b.
boolean
C0024301 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
rituximab refractory | Radioimmunotherapy Against CD20 Antigens refractory | Thrombotic Thrombocytopenic Purpura Duration Disease Response
Item
rituximab refractory or refractory to anti-cd20 radioimmunotherapy (no response to prior rituximab or prior rituximab-containing regimen, or a response with a ttp of less than 6 months).
boolean
C0393022 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C0085101 (UMLS CUI [2,1])
C0521124 (UMLS CUI [2,2])
C0054946 (UMLS CUI [2,3])
C0205269 (UMLS CUI [2,4])
C0034155 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
C1704632 (UMLS CUI [3,3])
Therapeutic radiology procedure Malignant Neoplasms | Biological treatment Malignant Neoplasms | Chemotherapy Malignant Neoplasms | Nitrosourea | Mitomycin-c
Item
cancer radiotherapy, biological therapy, or chemotherapy within 3 weeks prior to study day 1 (6 weeks if nitrosourea or mitomycin c).
boolean
C1522449 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C1531518 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
C0028210 (UMLS CUI [4])
C0002475 (UMLS CUI [5])
Vaccine Therapy Lymphoma
Item
prior lymphoma vaccine therapy within 12 months prior to study day 1.
boolean
C0042209 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
Antibody therapy Lymphoma | Radioimmunotherapy Lymphoma
Item
prior antibody therapy for lymphoma (including radioimmunotherapy) within 6 months prior to study day 1.
boolean
C0281176 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
C0085101 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])
Autologous bone marrow transplant | Transplantation of autologous hematopoietic stem cell
Item
autologous bone marrow or stem cell transplant within 6 months prior to study day 1.
boolean
C0194037 (UMLS CUI [1])
C1831743 (UMLS CUI [2])
Transplantation, Homologous
Item
prior allogeneic transplant.
boolean
C0040739 (UMLS CUI [1])
Blood transfusion dependent
Item
transfusion-dependent subjects.
boolean
C1698624 (UMLS CUI [1])
Primary tumor Requirement Therapeutic procedure | Hormone Therapy
Item
another primary malignancy requiring active treatment (except hormonal therapy).
boolean
C0677930 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2])
Disease Serious | Congestive heart failure | Hydronephrosis | Bacterial Infections Uncontrolled | Virus Diseases Uncontrolled | Mycoses Uncontrolled | Condition compromises Protocol Compliance
Item
serious nonmalignant disease (e.g., congestive heart failure, hydronephrosis); active uncontrolled bacterial, viral, or fungal infections; or other conditions, which would compromise protocol objectives in the opinion of the investigator and/or the sponsor.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0018802 (UMLS CUI [2])
C0020295 (UMLS CUI [3])
C0004623 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
C0042769 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0026946 (UMLS CUI [6,1])
C0205318 (UMLS CUI [6,2])
C0348080 (UMLS CUI [7,1])
C2945640 (UMLS CUI [7,2])
C0525058 (UMLS CUI [7,3])
Heart Disease New York Heart Association Classification | Myocardial Infarction
Item
new york heart association class iii or iv cardiac disease or myocardial infarction within 6 months prior to study day 1.
boolean
C0018799 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C0027051 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial